BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peña AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, Garad R, Dabadghao P, Teede H. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med 2020;18:72. [PMID: 32204714 DOI: 10.1186/s12916-020-01516-x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 37.0] [Reference Citation Analysis]
Number Citing Articles
1 Francis J, Menon S. Menstrual Problems and Vaginal Bleeding. Nelson Pediatric Symptom-Based Diagnosis: Common Diseases and their Mimics 2023. [DOI: 10.1016/b978-0-323-76174-1.00025-0] [Reference Citation Analysis]
2 Sahoo SM. Exploring the natural history of polycystic ovary syndrome: still a long road to traverse. Human Reproduction 2022. [DOI: 10.1093/humrep/deac252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Urbano F, Chiarito M, Lattanzio C, Messa A, Ferrante M, Francavilla M, Mehmeti I, Lassandro G, Giordano P, Faienza MF. Sex Hormone-Binding Globulin (SHBG) Reduction: The Alarm Bell for the Risk of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome. Children 2022;9:1748. [DOI: 10.3390/children9111748] [Reference Citation Analysis]
4 Tan H, Gao L, Guo Y, Liu Y, Ding R, Yan X, Wang X, Wang Y, Wang L. Development and evaluation of a psychological adjustment communication system for adolescents with polycystic ovary syndrome at a high risk of depression: A mixed-method study protocol. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.937280] [Reference Citation Analysis]
5 López-galisteo JP, Gavela-pérez T, Mejorado-molano FJ, Pérez-segura P, Aragón-gómez I, Garcés C, Soriano-guillén L. Prevalence and risk factors associated with different comorbidities in obese children and adolescents. Endocrinología, Diabetes y Nutrición (English ed ) 2022. [DOI: 10.1016/j.endien.2021.10.012] [Reference Citation Analysis]
6 Schweisberger CL, Hornberger L, Barral R, Burke C, Paprocki E, Sherman A, Vanden Brink H, Burgert TS. Gender diversity in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2022. [PMID: 36198004 DOI: 10.1515/jpem-2022-0249] [Reference Citation Analysis]
7 López-galisteo JP, Gavela-pérez T, Mejorado-molano FJ, Pérez-segura P, Aragón-gómez I, Garcés C, Soriano-guillén L. Prevalencia y factores de riesgo asociados a distintas comorbilidades en niños y adolescentes obesos. Endocrinología, Diabetes y Nutrición 2022;69:566-575. [DOI: 10.1016/j.endinu.2021.10.013] [Reference Citation Analysis]
8 Shah AS, Zeitler PS, Wong J, Pena AS, Wicklow B, Arslanian S, Chang N, Fu J, Dabadghao P, Pinhas-Hamiel O, Urakami T, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents. Pediatr Diabetes 2022. [PMID: 36161685 DOI: 10.1111/pedi.13409] [Reference Citation Analysis]
9 Lunddorf LLH, Arendt LH, Ernst A, Brix N, Knudsen UB, Olsen J, Ramlau-Hansen CH. Maternal polycystic ovarian syndrome and pubertal development in daughters and sons: a population-based cohort study. Hum Reprod 2022:deac197. [PMID: 36099165 DOI: 10.1093/humrep/deac197] [Reference Citation Analysis]
10 Ding R, Zhou H, Yan X, Liu Y, Guo Y, Tan H, Wang X, Wang Y, Wang L. Development and validation of a prediction model for depression in adolescents with polycystic ovary syndrome: A study protocol. Front Psychiatry 2022;13:984653. [DOI: 10.3389/fpsyt.2022.984653] [Reference Citation Analysis]
11 Peña AS, Codner E, Witchel S. Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review. Diagnostics 2022;12:1931. [DOI: 10.3390/diagnostics12081931] [Reference Citation Analysis]
12 Prajapati DP, Patel M, Dharamsi A. Beneficial effect of polyherbal formulation in letrozole induced Polycystic ovarian syndrome (PCOS). Journal of Traditional and Complementary Medicine 2022. [DOI: 10.1016/j.jtcme.2022.08.003] [Reference Citation Analysis]
13 Joham AE, Norman RJ, Stener-victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology 2022. [DOI: 10.1016/s2213-8587(22)00163-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sheng C, Zhang J, Jue J, Xi X. The Relationship between Ovarian Ultrasound Parameters and Endocrine and Metabolic Indicators in Patients with Ovarian Syndrome. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-6. [DOI: 10.1155/2022/7238344] [Reference Citation Analysis]
15 Kumar S, Sarathi V, Lila AR, Sehemby M, Memon SS, Karlekar M, Sankhe S, Patil VA, Shah N, Bandgar T. Giant prolactinoma in children and adolescents: a single-center experience and systematic review. Pituitary. [DOI: 10.1007/s11102-022-01250-y] [Reference Citation Analysis]
16 Jiang J, Gao S, Han T, Tang M. Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hCG) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/7933166] [Reference Citation Analysis]
17 Tayachew B, Vanden Brink H, Garcia-reyes Y, Rahat H, D'alessandro A, Frank DN, Robertson CE, Silveira L, Kelsey M, Pyle L, Cree-green M. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome. Front Physiol 2022;13:887077. [DOI: 10.3389/fphys.2022.887077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Norman RJ, Garad R, Teede H. The Classification of Polycystic Ovary Syndrome Informed by the International Guideline 2018. Polycystic Ovary Syndrome 2022. [DOI: 10.1017/9781108989831.005] [Reference Citation Analysis]
19 Naveen A, Ranjan Sahu M, Padhi KS, Mohanty MK. FORENSIC PERSPECTIVES OF PCOS AND ADOLESCENT SUICIDE: A CASE REPORT. ijsr 2022. [DOI: 10.36106/ijsr/8601441] [Reference Citation Analysis]
20 Manique MES, Ferreira AMAP. Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management. Rev Bras Ginecol Obstet 2022;44:425-33. [PMID: 35623621 DOI: 10.1055/s-0042-1742292] [Reference Citation Analysis]
21 Rajashekar S, Giri Ravindran S, Kakarla M, Ausaja Gambo M, Yousri Salama M, Haidar Ismail N, Tavalla P, Uppal P, Mohammed SA, Hamid P. Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review. Cureus. [DOI: 10.7759/cureus.25340] [Reference Citation Analysis]
22 van Berkel-zegers M, Lagro-janssen T. Wat is bij adolescenten een normaal menstruatiepatroon? Huisarts Wet 2022;65:57-61. [DOI: 10.1007/s12445-022-1444-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sergiyenko M, Siusiuka V, Makurina G, Deinichenko O, Kolokot N, Chornenka A. Modern approaches to the diagnosis and treatment of polycystic ovary syndrome in adolescence. RHW 2022. [DOI: 10.30841/2708-8731.2.2022.261816] [Reference Citation Analysis]
24 Siusiuka V, Makurina G, Chornenka A, Sergienko M, Yershova O. A multidisciplinary approach in the management of patients with acne. RHW 2022. [DOI: 10.30841/2708-8731.1.2022.258133] [Reference Citation Analysis]
25 Anderson Y, Chew CSE. Consequences of Childhood and Adolescent Obesity. Clinical Obesity in Adults and Children 2022. [DOI: 10.1002/9781119695257.ch26] [Reference Citation Analysis]
26 Joham AE, Peña AS. Polycystic Ovary Syndrome in Adolescence. Semin Reprod Med 2022;40:e1-8. [PMID: 36096151 DOI: 10.1055/s-0042-1757138] [Reference Citation Analysis]
27 Guzelkas I, Orbak Z, Doneray H, Ozturk N, Sagsoz N. Serum kisspeptin, leptin, neuropeptide Y, and neurokinin B levels in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2022. [PMID: 35170267 DOI: 10.1515/jpem-2021-0487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Adamyan LV, Andreeva EN, Absatarova YS, Grigoryan OR, Dedov II, Melnichenko GA, Suturina LV, Filippov OS, Sheremetyeva EV, Chernukha GE, Yarmolinskaya MI. Clinical guidelines «Polycystic Ovary Syndrome». Probl Endokrinol (Mosk) 2022;68:112-127. [DOI: 10.14341/probl12874] [Reference Citation Analysis]
29 Cioana M, Deng J, Nadarajah A, Hou M, Qiu Y, Chen SSJ, Rivas A, Banfield L, Alfaraidi H, Alotaibi A, Thabane L, Samaan MC. Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e2147454. [PMID: 35166782 DOI: 10.1001/jamanetworkopen.2021.47454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
30 Esquivel-Zuniga MR, Kirschner CK, McCartney CR, Burt Solorzano CM. Non-PCOS Hyperandrogenic Disorders in Adolescents. Semin Reprod Med 2022. [PMID: 35052005 DOI: 10.1055/s-0041-1742259] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pankhurst MW, Dillingham PW, Peña AS. Proteolytic activation of anti-Müllerian hormone is suppressed in adolescent girls. Endocrine 2022. [PMID: 34988934 DOI: 10.1007/s12020-021-02955-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bitzer J. Alterungsprävention in der Gendermedizin: Frauenmedizin. Präventionsmedizin und Anti-Aging-Medizin 2022. [DOI: 10.1007/978-3-662-61417-4_8] [Reference Citation Analysis]
33 Aubuchon M. Polycystic Ovarian Syndrome: A Diagnosis of Exclusion. Polycystic Ovary Syndrome 2022. [DOI: 10.1007/978-3-030-92589-5_3] [Reference Citation Analysis]
34 Papadimitriou K, Anagnostis P, Goulis DG. The challenging role of antiandrogens in the management of polycystic ovary syndrome. Polycystic Ovary Syndrome 2022. [DOI: 10.1016/b978-0-12-823045-9.00013-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Antoniou-tsigkos A, Pastroma K, Memi E, Vrachnis N, Mastorakos G. Combined oral contraceptives: Why, when, where? Polycystic Ovary Syndrome 2022. [DOI: 10.1016/b978-0-12-823045-9.00018-3] [Reference Citation Analysis]
36 Burgert TS, Paprocki E. Prevalence, Presentation, and Diagnosis of PCOS in Adolescents. Polycystic Ovary Syndrome 2022. [DOI: 10.1007/978-3-030-92589-5_2] [Reference Citation Analysis]
37 Islam H, Masud J, Islam YN, Haque FKM. An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Womens Health (Lond Engl) 2022;18:174550572211179. [DOI: 10.1177/17455057221117966] [Reference Citation Analysis]
38 Crisosto N. PCOS in adolescence: Pathophysiology, diagnostic challenges, and therapeutic controversies. Polycystic Ovary Syndrome 2022. [DOI: 10.1016/b978-0-12-823045-9.00001-8] [Reference Citation Analysis]
39 Laleli B, Timur B. Examination of Oxidative Stress Level in Adolescents with Polycystic Ovary Syndrome by Biochemical Parameters. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 2021;10:935-942. [DOI: 10.37989/gumussagbil.1003117] [Reference Citation Analysis]
40 Mizgier M, Watrowski R, Opydo-Szymaczek J, Jodłowska-Siewert E, Lombardi G, Kędzia W, Jarząbek-Bielecka G. Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome. Nutrients 2021;14:73. [PMID: 35010948 DOI: 10.3390/nu14010073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Shruti Shastry, Soumyashree Ghosh, Ruqayya Manasawala. In-Silico Screening of Prime PCOS Biomarkers for the Identification of a Potential Model Organism. IJSRST 2021. [DOI: 10.32628/ijsrst218665] [Reference Citation Analysis]
42 Garoufi A, Pagoni A, Papadaki M, Marmarinos A, Karapostolakis G, Michala L, Soldatou A. Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index. Children 2021;9:4. [DOI: 10.3390/children9010004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Nahidi F, Tehrani FR, Ghodsi D, Jafari M, Majd HA, Abdolahian S. The effectiveness of lifestyle training program promoting adolescent health with polycystic ovarian syndrome: A study protocol for a randomized controlled study. J Educ Health Promot 2021;10:351. [PMID: 34761037 DOI: 10.4103/jehp.jehp_15_21] [Reference Citation Analysis]
44 Danaei Mehr H, Polat H. Diagnosis of polycystic ovary syndrome through different machine learning and feature selection techniques. Health Technol 2022;12:137-50. [DOI: 10.1007/s12553-021-00613-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Conlon JL, Malcolm S, Monaghan M. Diagnosis and treatment of polycystic ovary syndrome in adolescents. JAAPA 2021;34:15-22. [PMID: 34524161 DOI: 10.1097/01.JAA.0000791468.37054.5d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Cao S, Hu Y. Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome. Biosci Rep 2021;41:BSR20211658. [PMID: 34427289 DOI: 10.1042/BSR20211658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Peña AS, Teede H, Hewawasam E, Hull ML, Gibson-Helm M. Diagnosis experiences of adolescents with polycystic ovary syndrome: Cross-sectional study. Clin Endocrinol (Oxf) 2022;96:62-9. [PMID: 34585425 DOI: 10.1111/cen.14604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
48 Dietz de Loos A, Hund M, Buck K, Meun C, Sillman J, Laven JSE. Antimüllerian hormone to determine polycystic ovarian morphology. Fertil Steril 2021;116:1149-57. [PMID: 34579824 DOI: 10.1016/j.fertnstert.2021.05.094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
49 Fu L, Qu F, Pan J, Wang T, Wang F. Polycystic ovary syndrome in adolescents with obesity. Rev Assoc Med Bras (1992) 2021;67:468-73. [PMID: 34468616 DOI: 10.1590/1806-9282.20200890] [Reference Citation Analysis]
50 de Vries L, Baum M, Horovitz M, Phillip M, Barash G, Pinhas-Hamiel O, Lazar L. Management of Fully Pubertal Girls With Nonclassical Congenital Adrenal Hyperplasia: Glucocorticoids Versus Oral Contraceptives. Endocr Pract 2021:S1530-891X(21)01176-9. [PMID: 34438053 DOI: 10.1016/j.eprac.2021.08.005] [Reference Citation Analysis]
51 Fernandez RC, Moore VM, Rumbold AR, Whitrow MJ, Avery JC, Davies MJ. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Hum Reprod 2021;36:2275-84. [PMID: 33963388 DOI: 10.1093/humrep/deab101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Samardzic T, Soucie K, Schramer K, Katzman R. “I didn’t feel normal”: Young Canadian women’s experiences with polycystic ovary syndrome. Feminism & Psychology 2021;31:571-90. [DOI: 10.1177/09593535211030748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Howard SR. Interpretation of reproductive hormones before, during and after the pubertal transition-Identifying health and disordered puberty. Clin Endocrinol (Oxf) 2021. [PMID: 34368982 DOI: 10.1111/cen.14578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Khan L. Polycystic Ovarian Syndrome in Adolescents: Keys to Diagnosis and Management. Pediatr Ann 2021;50:e272-5. [PMID: 34264796 DOI: 10.3928/19382359-20210622-01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Kostopoulou E, Anagnostis P, Bosdou JK, Spiliotis BE, Goulis DG. Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management. Curr Obes Rep 2020;9:193-203. [PMID: 32504286 DOI: 10.1007/s13679-020-00388-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
56 Tennilä J, Jääskeläinen J, Utriainen P, Voutilainen R, Häkkinen M, Auriola S, Morin-Papunen L, Liimatta J. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche. J Clin Endocrinol Metab 2021:dgab385. [PMID: 34060603 DOI: 10.1210/clinem/dgab385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Liu J, Wu Q, Hao Y, Jiao M, Wang X, Jiang S, Han L. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017. Hum Reprod 2021;36:1108-19. [PMID: 33501984 DOI: 10.1093/humrep/deaa371] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
58 de Zegher F, Diaz M, Ibañez L. From adolescent PCOS to adult MAFLD: opposing effects of randomised interventions. BMJ Open Gastroenterol 2021;8:e000574. [PMID: 34011622 DOI: 10.1136/bmjgast-2020-000574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Zhou S, Ji Y, Wang H. The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis. BMC Pregnancy Childbirth 2021;21:336. [PMID: 33906610 DOI: 10.1186/s12884-021-03808-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Rodriguez Paris V, Edwards MC, Aflatounian A, Bertoldo MJ, Ledger WL, Handelsman DJ, Gilchrist RB, Walters KA. Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model. J Endocr Soc 2021;5:bvab060. [PMID: 34056500 DOI: 10.1210/jendso/bvab060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
61 Torres OA, Miller E, Witchel SF. Quality Improvement in the Evaluation and Diagnosis of Polycystic Ovary Syndrome in Adolescent Girls. J Pediatr Adolesc Gynecol 2021;34:603-9. [PMID: 33689916 DOI: 10.1016/j.jpag.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hirschler V; Argentine Society of Diabetes, Paraguay 1307, Buenos Aires (1057), Argentina. . AIMSMEDS 2021;8:311-23. [DOI: 10.3934/medsci.2021026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Hillard PJA. Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescents. Reference Module in Biomedical Sciences 2021. [DOI: 10.1016/b978-0-12-818872-9.00018-2] [Reference Citation Analysis]
64 Sultan C, Gaspari L, Hamamah S, Paris F. Adolescence: A High-Risk Period for PCOS Development? ISGE Series 2021. [DOI: 10.1007/978-3-030-63650-0_2] [Reference Citation Analysis]
65 Zafar W, Khadija S, Rasool K, Fazal A, Sana A, Shazadi R. WHY THE RATE OF PCOS/PCOD INCREASE AT THE AGE OF MENARCHE. PBMJ 2020;4. [DOI: 10.54393/pbmj.v4i2.159] [Reference Citation Analysis]
66 Witchel SF, Pinto B, Burghard AC, Oberfield SE. Update on adrenarche. Curr Opin Pediatr 2020;32:574-81. [PMID: 32692055 DOI: 10.1097/MOP.0000000000000928] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
67 Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Bräuner EV, Hickey M. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study. Psychoneuroendocrinology 2021;125:105104. [PMID: 33352473 DOI: 10.1016/j.psyneuen.2020.105104] [Reference Citation Analysis]
68 Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab 2021;106:e1071-83. [PMID: 33211867 DOI: 10.1210/clinem/dgaa839] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 27.0] [Reference Citation Analysis]
69 de Medeiros SF, de Medeiros MAS, Barbosa BB, Yamamoto MMW, Maciel GAR. Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome. Arch Gynecol Obstet 2021;303:739-49. [PMID: 33201375 DOI: 10.1007/s00404-020-05867-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
70 Rizk MG, Thackray VG. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome. J Endocr Soc 2021;5:bvaa177. [PMID: 33381671 DOI: 10.1210/jendso/bvaa177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
71 Panayiotopoulos A, Bhangoo A, Khurana D, Ten S, Michl J, Ghanny S. Response to Letter to the Editor: "Glucocorticoid Resistance in Premature Adrenarche and PCOS: From Childhood to Adulthood". J Endocr Soc 2021;5:bvaa166. [PMID: 33381669 DOI: 10.1210/jendso/bvaa166] [Reference Citation Analysis]
72 Shah K, Kulkarni R, Singh R, Pannu HS, Kamrai D. Role of Bupropion and Naltrexone in Managing Depression With Polycystic Ovary Syndrome: A Case Report and Literature Review. Cureus 2020. [DOI: 10.7759/cureus.11343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Witchel SF, Plant TM. Intertwined reproductive endocrinology: Puberty and polycystic ovary syndrome. Current Opinion in Endocrine and Metabolic Research 2020;14:127-136. [DOI: 10.1016/j.coemr.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Nicolaides NC, Matheou A, Vlachou F, Neocleous V, Skordis N. Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management. Acta Biomed 2020;91:e2020085. [PMID: 32921781 DOI: 10.23750/abm.v91i3.10162] [Reference Citation Analysis]
75 Fitzgerald S, Stamoulis C, Gooding HC, DiVasta AD. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes. J Pediatr Adolesc Gynecol 2020;33:697-702. [PMID: 32889085 DOI: 10.1016/j.jpag.2020.08.015] [Reference Citation Analysis]
76 Wilson NA, Peña AS. Quality of life in adolescent girls with polycystic ovary syndrome. J Paediatr Child Health 2020;56:1351-7. [DOI: 10.1111/jpc.15097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
77 Lidaka L, Grasmane A, Lazdane G, Dzivite-Krisane I, Gailite L, Viberga I. Can a mother's polycystic ovary syndrome (PCOS)-related symptoms be used to predict the future clinical profile of PCOS in her adolescent daughter? A pilot study. Eur J Contracept Reprod Health Care 2021;26:17-22. [PMID: 32757787 DOI: 10.1080/13625187.2020.1795118] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Rosenfield RL. Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. J Pediatr Adolesc Gynecol 2020;33:445-7. [PMID: 32615268 DOI: 10.1016/j.jpag.2020.06.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
79 Garad RM, Teede HJ. Polycystic ovary syndrome: improving policies, awareness, and clinical care. Current Opinion in Endocrine and Metabolic Research 2020;12:112-118. [DOI: 10.1016/j.coemr.2020.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]